News
Fideres Writes To The European Commission To Flag The Anticompetitive Implications Of IBAN Discrimination
Fideres flags the anticompetitive implications of IBAN discrimination with the European Commission.
Fideres’s research on generic drug pricing was covered today by Bloomberg. The research analysed price increases for individual generic drugs among different manufacturers and the timings of these price increases. The coverage of Fideres’s work comes as the Department of Justice continues their investigation into alleged collusion by drug manufacturers.
The full article can be found here.
Fideres flags the anticompetitive implications of IBAN discrimination with the European Commission.
Today, Fideres has urged the CNMV to take action against the use of encrypted chats (WhatsApp, Telegram etc.) by financial institutions in Spain. I...
The Italian law firm Scoccini & Associati and the Spanish law firm CCS Abogados, supported by the litigation fund ALI – Antritrust Litigation...
London: +44 20 3397 5160
New York: +1 646 992 8510
Rome: +39 06 8587 0405
Frankfurt: +49 61 7491 63000
Johannesburg: +27 11 568 9611
Madrid: +34 919 494 330